<?xml version="1.0" encoding="UTF-8"?>
<p id="Par103">At approximately 100 days following completion of trial ASCT and assessment for response, eligible participants (see Table 
 <xref rid="Tab3" ref-type="table">3</xref> for details) will undergo the second 1:1 randomisation (R2) to receive consolidation and maintenance or no further treatment.
</p>
